random placebo-control trial intraven captopril recombin tissue-typ plasminogen activ therapi acut myocardi infarct adjunct use intraven captopril tissu plasminogen activ earli acut myocardi infarct offer theoret advantag left ventricular volum ventricular dilat patient surviv safeti efficaci earli administr intraven captopril recombin tissue-typ plasminogen activ rt-pa patient rt-pa mean SE onset myocardi infarct intraven oral captopril placebo therapi underw cardiac catheter measur hemodynam variabl ventricular function determin serum renin angiotensin aldosteron level day oral administr agent month antiangin medic nonangiotensin-convert enzym inhibitor vasodil repeat measur left ventricular function hospit discharg month signific differ baselin clinic characterist group patient captopril-tr group hypotens intraven therapi discontinu treatment placebo-tr group captopril-tr group signific reduct day left ventricular end-diastol pressur versu mm Hg mean system arteri pressur versu mm Hg 